losoxantrone has been researched along with Nausea in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baker, SD; Burris, HA; Cobb, PW; Diab, SG; Drengler, R; Eckhardt, SG; Finizio, M; Hammond, L; Joshi, A; Kraynak, M; Rodriguez, GI; Rowinsky, EK; Villalona-Calero, MA; Von Hoff, DD; Weiss, GR | 1 |
Finizio, M; Huan, SD; Natale, RB; Roberts, JD; Sartiano, GP; Stella, PJ; Stewart, DJ; Symes, AL | 1 |
2 trial(s) available for losoxantrone and Nausea
Article | Year |
---|---|
A phase I and pharmacokinetic study of losoxantrone and paclitaxel in patients with advanced solid tumors.
Topics: Adult; Aged; Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Feasibility Studies; Follow-Up Studies; Heart Failure; Humans; Immunosuppression Therapy; Middle Aged; Nausea; Neoplasms; Paclitaxel; Pyrazoles; Pyrazolones; Treatment Outcome | 1999 |
A multicenter phase II trial of losoxantrone (DuP-941) in hormone-refractory metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Anorexia; Anthraquinones; Antineoplastic Agents; Bone Neoplasms; Diarrhea; Drug Resistance, Neoplasm; Follow-Up Studies; Heart Ventricles; Hematologic Diseases; Hormones; Humans; Liver Neoplasms; Male; Middle Aged; Nausea; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms; Pyrazoles; Pyrazolones; Stomatitis; Survival Analysis; Vomiting | 2000 |